Larger studies will now be necessary to confirm this result and test the effects on recovery from stroke.
Amit Mistri, a postgraduate researcher working on this project commented: “Stroke is a debilitating condition with high death and dependency rates. There are many unanswered dilemmas in the early management of people who have suffered a stroke.
“For early treatment of strokes caused by a clot in the circulation, aspirin is the only medication shown to be beneficial (small benefit), and clot-dissolving treatment (thrombolysis) is applicable to a minority only. No evidence-based treatment exists for early management of strokes secondary to bleeding within the brain. Elevated blood pressure represents a new therapeutic target in the early management of both types of stroke.”
The research was funded and sponsored by the National Health Service Research and Development Health Technology Assessment Programme of the Department of Health.
Elevated peak arterial blood pressure (systolic blood pressure - SBP) following a stroke has been associated with worse outcome. It is not known whether early lowering of high SBP would be beneficial in improving outcome following stroke.
The research in Leicester was carried out as part of CHHIPS, a multicentre UK-based study, which compared the SBP lowering efficacy of two medications (labetalol and lisinopril) with dummy medication (placebo).
179 patients with high SBP (>160 mmHg) were randomly allocated to receive labetalol, lisinopril or a placebo. The dose was increased over the first 12 hours to attain a pre-specified SBP target, and continued for 2 weeks. Alternative formulations were available for those unable to swallow.
From a baseline SBP of 182 mmHg, average reduction of SBP at 24 hours in the individual groups was: labetalol-18, lisinopril-25, and placebo-11 mmHg. Active medication reduced SBP more than placebo at 24 hours. Both medications studied were not associated with an increase in further deterioration or adverse effects, compared to placebo.
Amit Mistri developed an interest in stroke research, during his training in Geriatric Medicine. The research was carried out in the Ageing & Stroke Medicine section of the Department of Cardiovascular Sciences, where he was a clinical research fellow, and the trial coordinator for the multi-centre CHHIPS study. His interests include: blood pressure in acute stroke, participation of stroke patients in research trials, epidemiology of stroke, and risk factor modification for secondary prevention of stroke.
The research is being presented to the public at the University of Leicester on Thursday 26th June. The Festival of Postgraduate Research introduces employers and the public to the next generation of innovators and cutting-edge researchers, and gives postgraduate researchers the opportunity to explain the real world implications of their research to a wide ranging audience.
More information about the Festival of Postgraduate Research is available at: www.le.ac.uk/gradschool/festival
Ather Mirza | alfa
Researchers simplify tiny structures' construction drip by drip
12.11.2018 | Princeton University, Engineering School
Mandibular movement monitoring may help improve oral sleep apnea devices
06.11.2018 | Elsevier
Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.
In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...
On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.
When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure
Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...
Physicists at ETH Zurich demonstrate how errors that occur during the manipulation of quantum system can be monitored and corrected on the fly
The field of quantum computation has seen tremendous progress in recent years. Bit by bit, quantum devices start to challenge conventional computers, at least...
Scientists developed specially coated nanometer-sized vehicles that can be actively moved through dense tissue like the vitreous of the eye. So far, the transport of nano-vehicles has only been demonstrated in model systems or biological fluids, but not in real tissue. The work was published in the journal Science Advances and constitutes one step further towards nanorobots becoming minimally-invasive tools for precisely delivering medicine to where it is needed.
Researchers of the “Micro, Nano and Molecular Systems” Lab at the Max Planck Institute for Intelligent Systems in Stuttgart, together with an international...
09.11.2018 | Event News
06.11.2018 | Event News
23.10.2018 | Event News
12.11.2018 | Life Sciences
12.11.2018 | Materials Sciences
12.11.2018 | Physics and Astronomy